IS
IS · IS · IS-EU/1/25/1917/002
Lynozyfic
ATC L01FX
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerRegeneron Ireland Designated Activity Company
CountryIS (IS)
ATC codeL01FX
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "L01FX",
"marketed": false,
"strength": "200 mg",
"ma_number": "EU/1/25/1917/002",
"substance": "Linvoseltamab",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "45770"
}Related drugs
Other records sharing ATC code L01FX.
- NLColumvi 10 mg concentraat voor oplossing voor infusieRoche Registration GmbH
- NLColumvi 2,5 mg concentraat voor oplossing voor infusieRoche Registration GmbH
- PLDatrowayDaiichi Sankyo Europe GmbH
- PLElrexfioPfizer Europe MA EEIG
- PLIMDYLLTRAAmgen Europe B.V.
- PLIMDYLLTRAAmgen Europe B.V.
- ISLynozyficRegeneron Ireland Designated Activity Company
- 🇺🇸LYNOZYFICRegeneron Pharmaceuticals, Inc.
Access this data programmatically
Query Lynozyfic and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.